Arcadia Biosciences (RKDA) Tops Q4 EPS by $1.31

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of $0.90, $1.31 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $1.26 thousand.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• Harley-Davidson (HOG) PT Raised to $30 at DA Davidson: 'Moving in The Right Direction'
• Deutsche sees attractive entry point in Consumer Staples, Real Estate